期刊文献+

阿司匹林抵抗对大动脉粥样硬化性脑梗死复发的影响 被引量:12

The influence of aspirin resistance on cerebral infarction recurrence with large artery atherosclerosis
原文传递
导出
摘要 目的观察阿司匹林抵抗(aspirinresistance,AR)对大动脉粥样硬化性脑梗死(large artery ath erosclerosis cerebral infarction,L从CI)复发的影响。方法选择阳东县人民医院首次发生LAACI患者269例,人院后即服用阿司匹林200mg,在7-10d后利用比浊法检测血小板聚集率,分为AR组40例,阿司匹林敏感组(aspirin sensitivity,AS)229例,进行随访6~12个月;根据脑梗塞复发的情况分为大动脉粥样硬化复发(largeartery atherosclerosi srecurrence,LAAR)组38例和大动脉粥样硬化无复发(notlarge artery athero sclerosis recurrence,NLAAR)组231例,观察AR患者的危险因素,同时观察LAAR与AR之间的关系。结果单因素分析中AR组的LAAR显著高于AS组(34.2%vs11.7%,P=0.000),跟NLAAR组比较LAAR组患糖尿病、AR、年龄较大的比例均明显升高(P〈0.05或0.01);多因素分析中LAAR与AR明显相关(OR=4.692,95%CI=1.052~15.675,P=0.005)。结论AR是LAAR的独立危险因素,能够增加LAAR的风险。 Objective To observe the influence of aspirin resistance on cerebral infarction recurrence with large artery atherosclerosis and the long-term curative effect of aspirin. Methods We collected 269 patients with ischemic stroke during November 2012 to November 2013 in Department of Neurology of yang-dong People's hospital, all patients took aspirin 200 mg/d , and then were divided into AR group and aspirin sensitivity(AS)group according to use Turbidimetry to measure the platelet aggregation rate after taking aspirin 7 0 10 d. Depending on the recurrence of cerebral infarction, the patients were divided into the group of large artery atherosclerosis recurrence (LAAR)group (229 cases)and not large artery atherosclerosis recurrence (NLAAR) group(231 cases)after following up 6-12 months, and observed the risk factors of patients with AR and the relationship between LAAR and AR. Results In single factor analysis, LAAR in AR group was significantly higher than the AS group (vs 11.7- 34. 2%, P = 0. 000). LAAR in patients in LAAR with dia- betes, AR, older were significant different (P〈0. 05 or 0. 01), compared with NLAAR group. In multiple factors analysis, LAAR was significantly related with AR (OR = 4. 692, 95% CI = 1. 052- 15. 675, P = 0. 005). Conclusions AR is independent risk factors of LAAR, and can increase the risk of LAAR.
出处 《卒中与神经疾病》 2015年第4期219-221,225,共4页 Stroke and Nervous Diseases
关键词 阿司匹林抵抗 动脉粥样硬化 脑梗死 血小板聚集率 Aspirin resistance Atherosclerosis Cerebral infarction Platelet aggregation rate
  • 相关文献

参考文献3

二级参考文献13

  • 1高山.大脑中动脉狭窄患者急性脑梗死发病机制:一项弥散加权磁共振和微栓子监测研究[J].中国卒中杂志,2006,1(7):526-529. 被引量:4
  • 2Gasparyan AY.Aspirin and clopidogrel resistance:methodologicalchallenges and opportunities[J].Vascular Health and Risk Man-agement,2010,6(8):109-112.
  • 3Sharma RK,Reddy HK,Singh VN,et al.Aspirin and clopidogrelhyporesponsiveness and nonresponsiveness in patients with coro-nary artery stenting[J].VASC Health Risk Manag,2009,5(3):965-972.
  • 4Lev EI,Patel RT,Maresh KJ,et al.Aspirin and clopidogrel drugresponse in patients undergoing percutaneous coronary interven-tion:the role of dual drug resistance[J].J Am COIL Cardiol,2006,47(1):27-33.
  • 5Barragan P,Bouvier JL,Roquebert PO,et al.Resistance to thien-opyridines:clini-phosphoprotein phosphorylation[J].CatheterCardiovasc Interv,2003,59(3):295-302.
  • 6Gum PA,Kottke KM,Poggio ED,et al.Profile and prevalence ofaspirin resistance in patients with cardiovascular disease[J].Am JCardiol,2001,88(3):230-235.
  • 7Gurebl P,Becker RC,Mann KG,et al.Platelet function monito-ring in patients with coronary artery disease[J].J Am COLL Car-diol,2007,50(19):1822-1834.
  • 8Harrison P.Platelet function analysis[J].Blood Reviews,2005,19(9):111-123.
  • 9Takuya F,Daisuke F,Takeda H,et al.Evaluation of clopidogrelresistance in ischemic stroke patients[J].Internal Medicine,2011,50(22):31-35.
  • 10Matsuno H,Tokuda H,Ishisaki A,et al.P2Y12receptors play asignificant role in the development of platelet microaggregation inpatients with diabetes[J].J CLIN Endocrinol Metab,2005,90(2):920-927.

共引文献625

同被引文献91

引证文献12

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部